Abstracts Archive - Page 2181 of 2425 - ACR Meeting Abstracts

Abstract Number: 1043 • 2013 ACR/ARHP Annual Meeting
Musculoskeletal Hospital Admissions Among Patients Treated For Rheumatoid Arthritis Between 1999 and 2010 Compared With The General Population In The Netherlands
I D Bezemer¹, L M A Houweling¹, E Alemao², F J A Penning-van Beest¹ and M Hochberg³, ¹PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands, ²Bristol-Myers Squibb, Princeton, NJ, ³University of Maryland, Baltimore, MD
Background/Purpose: Advances in treatment for RA may have resulted in a decrease in musculoskeletal hospital admissions. This study aimed to assess the trends in hospital…
Abstract Number: 1044 • 2013 ACR/ARHP Annual Meeting
Temporal Associations Of Prevalent Depression With The Different Domains Of Rheumatoid Arthritis Disease Activity
Alan Rathbun¹, Leslie R. Harrold² and George Reed³, ¹Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester, MA, ²University of Massachusetts Medical School, Worcester, MA, ³Division of Behavioral and Preventive Medicine, University of Massachusetts Medical School, Worcester, MA
Background/Purpose: Depression (DEP) is a common psychiatric comorbidity of rheumatoid arthritis (RA), yet little is known of its temporal effect on disease activity and symptoms. …
Abstract Number: 1045 • 2013 ACR/ARHP Annual Meeting
Under Reporting Of Cataracts In Randomised Controlled Trials Investigating The Use Of Systemic Glucocorticoids In Patients With Rheumatoid Arthritis
Rachel J. Black^1,2 and William G. Dixon³, ¹Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, ²Department of Medicine, The University of Adelaide, Adelaide, Australia, ³The University of Manchester, Manchester, United Kingdom
Background/Purpose: Oral glucocorticoid (GC) therapy is used in more than half of patients with rheumatoid arthritis (RA). Cataracts are a recognised treatment-related side effect of…
Abstract Number: 1046 • 2013 ACR/ARHP Annual Meeting
Comparison Of The Incidence Of Influenza Like Illness In Pregnant Women With Rheumatoid Arthritis and Women Without Rheumatoid Arthritis Who Receive An Influenza Vaccination
Yunjun Luo¹, Diana L. Johnson², Ronghui Xu³ and Christina D. Chambers¹, ¹Pediatrics, University of California, San Diego, La Jolla, CA, ²University of California San Diego Department of Pediatrics, La Jolla, CA, ³Family and Preventive Medicine, University of California, San Diego, La Jolla, CA
Background/Purpose: Influenza infection poses significant risk to pregnant women, therefore it is recommended that all pregnant women be vaccinated. However, it is unknown whether the…
Abstract Number: 1047 • 2013 ACR/ARHP Annual Meeting
Rates Of Hospitalized Infections In Rheumatoid Arthritis Patients From 5 Rheumatoid Arthritis Registries Across The World
Hisashi Yamanaka¹, Johan Askling², Niklas Berglind³, Stefan Franzén³, Thomas Frisell⁴, Christopher Garwood⁵, Jeffrey D. Greenberg⁶, Meilien Ho⁷, Marie Holmqvist², Laura Horne⁸, Eisuke Inoue¹, Kathy Lampl⁹, Kaleb Michaud¹⁰, Dimitrios A. Pappas¹¹, George Reed¹², Deborah Symmons⁵, Eiichi Tanaka¹³, Trung Tran¹⁴, Suzanne Verstappen⁵ and Fredrik Nyberg¹⁵, ¹Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, ²Karolinska Institutet, Stockholm, Sweden, ³AstraZeneca R&D Mölndal, Mölndal, Sweden, ⁴Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, ⁵Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, ⁶New York Hospital for Joint Disease, New York, NY, ⁷AstraZeneca R&D Alderley Park, Macclesfield, United Kingdom, ⁸AstraZeneca, Wilmington, DE, ⁹AstraZeneca R&D Wilmington, Wilmington, DE, ¹⁰University of Nebraska Medical Center, Omaha, NE, ¹¹Columbia University, New York, NY, ¹²University of Massachusetts Medical School, Worcester, MA, ¹³Tokyo Women's Medical University, Tokyo, Japan, ¹⁴MedImmune LLC, Gaithersburg, MD, ¹⁵AstraZeneca R&D, Mölndal, Sweden
Background/Purpose: Rheumatoid arthritis (RA) patients are at increased risk of infection due to both RA itself and immunomodulating treatments. Infection rates are often difficult to…
Abstract Number: 1048 • 2013 ACR/ARHP Annual Meeting
Generalizability Of a U.S. Rheumatoid Arthritis Registry: A Comparison Of Participants’ Vs. Non-Participants’ Characteristics
Jeffrey R. Curtis¹, Lang Chen², Huifeng Yun³, Leslie R. Harrold⁴, Jeffrey D. Greenberg⁵ and Joel M. Kremer⁶, ¹University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology, Birmingham, AL, ²Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³Epidemiology, University of Alabama at Birmingham, Birmingham, AL, ⁴University of Massachusetts Medical School, Worcester, MA, ⁵Departments of Medicine (Rheum Div) and Hospital for Joint Diseases, New York Hospital for Joint Diseases, New York, NY, ⁶Center for Rheumatology, Albany Medical College, Albany, NY
Background/Purpose: Observational registries provide a valuable complement to clinical trials yet might suffer from limited generalizability referent to the desired population of interest. We compared…
Abstract Number: 1049 • 2013 ACR/ARHP Annual Meeting
Formal Education Level Explains Variation In Rheumatoid Arthritis (RA) Core Data Set Measures and Indices In Korean Patients At Higher Levels Of Significance Than Age, Sex, and Duration Of Disease
Sung-Hoon Park^1,2, Isabel Castrejón³, Jung-Yoon Choe¹, Seong-Kyu Kim¹, Hwajeong Lee¹, Sang Gyu Kwak¹ and Theodore Pincus³, ¹Catholic University of Daegu School of Medicine, Daegu, South Korea, ²NYU Hospital for Joint Diseases and New York University School of Medicine, New York, NY, ³Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: Poor health is associated with low socioeconomic status (SES), with higher prevalence, greater severity and earlier mortality of many diseases, including rheumatoid arthritis (RA).…
Abstract Number: 1050 • 2013 ACR/ARHP Annual Meeting
Population-Based Analysis Of Treatment Patterns For Recently Diagnosed Rheumatoid Arthritis Patients In The United States
Martin M. Crane¹, Boyka Stoykova², Julie Priest¹, Nasha Wang¹, Henry Krzywy¹ and Rahul Ganguly³, ¹WW Epidemiology, GlaxoSmithKline, Durham, NC, ²Global Health Outcomes, GlaxoSmithKline, Uxbridge, United Kingdom, ³Global Health Outcomes, GlaxoSmithKline, Durham, NC
Background/Purpose: As treatment paradigms for rheumatoid arthritis (RA) continue to evolve, population-based studies can help assess which strategies are being used in “real-world” practice for…
Abstract Number: 1051 • 2013 ACR/ARHP Annual Meeting
Sociodemographic, Health System, and Community Characteristics Associated With Initiation Of Biological Dmards In RA
Edward H. Yelin¹, Chris Tonner², Seoyoung C. Kim³, Jeffrey N. Katz⁴, John Z. Ayanian⁵ and Daniel H. Solomon⁶, ¹Medicine, UC San Francisco, San Francisco, CA, ²Medicine, University of California, San Francisco, San Francisco, CA, ³Div. of Pharmacoepidemiology and Pharmacoeconomics, Div. of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁴Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA, ⁵Brigham and Women's Hospital, Boston, MA, ⁶Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA
Background/Purpose: The use of biologic DMARDs for RA has improved outcomes, but it is unknown whether there are disparities in initiation of these agents by…
Abstract Number: 1018 • 2013 ACR/ARHP Annual Meeting
Methodology Of Determining An Appropriate Look-Back Period To Identify Autoimmune Rheumatic Disease In a Study Of Post-Myocardial Infarction Mortality
Mark Tacey, Megan Bohensky and Sharon Van Doornum, Melbourne EpiCentre, The University of Melbourne, Melbourne, Australia
Background/Purpose: Hospital administrative datasets offer an opportunity to study the relatively rare occurrence of auto-immune rheumatic diseases (AIRD). Under-coding is a known limitation however. “Look-back”…
Abstract Number: 1011 • 2013 ACR/ARHP Annual Meeting
Psychiatric and Cardiovascular Comorbidities As Causes Of Work Disability Among Individuals With Rheumatoid Arthritis
Anne M. Kerola¹, Tuomo Nieminen², Markku J. Kauppi³, Hannu Kautiainen⁴, Tuomas Kerola³, Lauri J. Virta⁵, Timo Pohjolainen⁶ and Kari Puolakka⁷, ¹Medical School, University of Helsinki, Helsinki, Finland, ²Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland, ³Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland, ⁴Unit of Primary Health Care, Helsinki University Central Hospital, Helsinki, Finland, ⁵Research Department, the Social Insurance Institution, Turku, Finland, ⁶ORTON Rehabilitation Centre, ORTON Foundation, Helsinki, Finland, ⁷Department of Medicine, South Karelia Central Hospital, Lappeenranta, Finland
Background/Purpose: A remarkable proportion of rheumatoid arthritis (RA) patients stop working before the normal age of retirement. Initial research data suggests that comorbidities, with depression…
Abstract Number: 1012 • 2013 ACR/ARHP Annual Meeting
Disease Severity, Quality Of Life, and Productivity Loss Among Patients With Ankylosing Spondylitis In Germany
Jürgen Braun¹, Herbert Kellner², Regina Max³, Markus Rihl⁴, Elmar Schmitz-Bortz⁵, Hendrik Schulze-Koops⁶, Silke Zinke⁷, Tao Fan⁸, Qian Ding⁹ and Ramon Lyu⁹, ¹Rheumazentrum Ruhrgebiet, Herne, Germany, ²Centre for Inflammatory Joint Diseases, Munich, Germany, ³University of Heidelberg, Heidelberg, Germany, ⁴German Society for Rheumatology Association, Traunstein, Germany, ⁵Rheumatology practice, Hattingen, Germany, ⁶Division of Rheumatology, University of Munich, Munich, Germany, ⁷Rheumatological Office, Berlin, Germany, ⁸Merck & Co., Inc., Whitehouse Station, NJ, ⁹Merck & Co., Inc, Whitehouse Station, NJ
Background/Purpose: Ankylosing Spondylitis (AS) is a chronic, inflammatory form of arthritis that primarily affects the spine, which can cause significant pain and lead to bone…
Abstract Number: 1013 • 2013 ACR/ARHP Annual Meeting
Estimating the Monetary Value of annual Productivity Gained in Early Active RA Patients Receiving Etanercept Plus Methotrexate: Results From the Prize Study
Wei Zhang¹, Nick Bansback², Huiying Sun¹, Ronald Pedersen³, Sameer Kotak⁴ and Aslam H. Anis^1,2, ¹St. Paul's Hospital, Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada, ²School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada, ³Specialty Care, Pfizer Inc, Collegeville, PA, ⁴Specialty Care, Pfizer Inc., New York, NY
Background/Purpose: Determining the effect of treatment on work productivity of subjects with rheumatoid arthritis (RA) is an important topic given that most sufferers develop the…
Abstract Number: 1014 • 2013 ACR/ARHP Annual Meeting
Test-Retest Reliability Of Five Global Measures Addressing At Work Limitations/Productivity Loss In Patients With Rheumatological Conditions
Sarah Leggett¹, Annelies Boonen², Diane Lacaille³, Dorcas Beaton⁴, Bruno Fautrel⁵, Ailsa Bosworth⁶, Catherine Hoffstetter⁷, Sabrina Dadoun⁵, Carlo Alberto Scirè⁸, Sofia Hagel⁹, Mihai Bojinca¹⁰, Carina Mihai¹¹, Antje Neuen¹², Pam Rogers¹³, Denise Linton¹⁴, Ingemar Petersson¹⁵ and Suzanne Verstappen¹⁶, ¹Arthritis Research UK Epidemiology Unit, Manchester Academic Health Science Centre,The University of Manchester, Manchester, United Kingdom, ²Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ³Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada, ⁴Scientist, Institute for Work & Health, Toronto, ON, Canada, ⁵APHP, Pitié-Salpêtrière University Hospital, Paris, France, ⁶National Rheumatoid Arthritis Society, Maidenhead, United Kingdom, ⁷Patient partner, Toronto, ON, Canada, ⁸Epidemiology Unit -Italian Society for Rheumatology, Milano, Italy, ⁹Department of Clinical Sciences Lund, Section for Rheumatology, Lund, Lund University and Skåne University Hospital, Lund, Sweden, ¹⁰Internal Medicine, “Dr. I. Cantacuzino” Hospital, Bucharest, Romania, ¹¹Department of Internal Medicine and Rheumatology, Dr.I.Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, ¹²University Hospital Maastricht, Internal Medicine, Division of Rheumatology, Maastricht, Netherlands, ¹³Rheumatology, Arthritis Research Centre, Vancouver, BC, Canada, ¹⁴Mobility Clinical Research Unit, St. Michael's Hospital, Toronto, ON, Canada, ¹⁵Lund University, Department of Orthopedics, Clinical Sciences Lund, Lund, Sweden, ¹⁶Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom
Background/Purpose: There are a number of single item global measures available to explore at-work productivity loss (presenteeism) in patients with rheumatological conditions. However, test-retest data…
Abstract Number: 1015 • 2013 ACR/ARHP Annual Meeting
Quality Of Life, Productivity Impairment, Disease Severity and Health Care Costs In Relation To Functional Impairment In Ankylosing Spondylitis Patients In The Czech Republic
Liliana Sedova^1,2, Jiri Stolfa^1,2, David Suchy³, Andrea Smrzova⁴, Jiri Klimes⁵, Milan Vocelka⁵ and Tomas Dolezal⁵, ¹Institute of Rheumatology, Prague, Czech Republic, ²Clinic of Rheumatology, Charles University Prague, Prague, Czech Republic, ³Department of Clinical Pharmacology, Rheumatology, University hospital Plzen, Plzen, Czech Republic, ⁴3rd internal clinic, University hospital Olomouc, Olomouc, Czech Republic, ⁵Institute of Health Economics and Technology Assessment, Charles University, Prague, Czech Republic
Background/Purpose: Our aim was to describe the quality-of-life (QoL), productivity impairment, clinical indicators and health care costs in relationship to functional status described by Bath…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].